Atrophic Gastritis Predicts the Risk of Gastric Cancer

Launched by SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE · Jan 11, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how atrophic gastritis, a condition where the stomach lining becomes thinner, can increase the risk of developing gastric cancer, particularly in areas where this type of cancer is more common. Gastric cancer is a serious disease, but if caught early, patients have a much better chance of survival. The researchers want to understand how often gastric cancer occurs in people with atrophic gastritis, which is important for improving early detection and treatment.

To participate in this study, you need to be between 18 and 80 years old and willing to provide informed consent, meaning you agree to take part after understanding what the study involves. People who have had their stomachs removed or have serious health issues may not be eligible. If you join the study, you can expect to have biopsies taken, which are small samples of tissue, to help researchers gather the necessary information. This research could lead to better ways to identify and treat gastric cancer in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Ability and willingness to participate in the study and to sign and give informed consent
• • Biopsies were collected based on the recommendation of updated Sydney system
• Exclusion Criteria:
• • under 18 or over 80 years old
• • history of gastrectomy
• • severe systemic diseases or malignancy